Clinical Trials Browser

Phase 2 × Brain Neoplasms × pexidartinib × Clear all

NCT01349036 2020-03-03

A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma

Phase 2 Terminated

38 enrolled 13 charts

Brain Neoplasms, Glioblastoma